the concentrations for 50 percent inhibition ( ranging from 11.5 nanomolar for spiroperidol to 800 nanomolar for thioridazine ) correlated closely with the average daily dosages of 25 neuroleptic drugs used clinically for schizophrenia .
C0039943
thioridazine
C0036341
schizophrenia